Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea
Jul 13, 2022 14:30 HKT |  |
|
SinoMab Received the Highest Subsidy from HKSTP
Jul 08, 2022 19:03 HKT |  |
|
Malaysian Genomics Proposes Private Placement
Jul 08, 2022 18:00 HKT |  |
|
Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB
Jul 07, 2022 19:13 HKT |  |
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles
Jul 06, 2022 16:00 HKT | |
|
Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022
Jun 30, 2022 10:42 HKT |  |
|
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery
Jun 29, 2022 18:22 HKT |  |
|
Novotech Receives "Best Biologics CRO Award 2022" at Korea Bioprocessing Excellence Awards 2022
Jun 29, 2022 07:00 HKT | |
|
Novel patching material for bone defects
Jun 27, 2022 17:00 HKT |  |
|
EC Healthcare Received "Institutional Investor" 2022 Multiple Awards in All-Asia Executive Team Rankings
Jun 27, 2022 11:42 HKT |  |
|
Malaysian Genomics Resource Centre to Offer Pioneering Holistic Renal Care via New Venture
Jun 23, 2022 14:30 HKT | |
|
EC Healthcare Announces FY2021/22 Annual Results
Jun 23, 2022 13:46 HKT | |
|
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations
Jun 23, 2022 08:00 HKT | |
|
Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead(TM) Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium
Jun 21, 2022 23:45 HKT | |
|
The Mechanism of Action of SinoMab's Flagship Product SM03 is Successfully Published in the Journal of Immunology, a Reputable Journal on Immunology in the U.S.
Jun 21, 2022 15:38 HKT | |
|
EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry
Jun 21, 2022 12:48 HKT | |
|
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology
Jun 16, 2022 11:42 HKT | |
|
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
Jun 15, 2022 13:03 HKT | |
|
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
Jun 15, 2022 12:08 HKT | |
|
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development
Jun 15, 2022 08:30 HKT |  |
|